APPA Quarterly General Meeting
3.00pm – 6.00pm 13th December, 2010
Curzon Hall, 53 Agincourt Rd, Marsfield
Special Guest Speaker: Dr Brendan Shaw, Chief Executive, Medicines Australia Limited
APPA is pleased to be able to provide you with the opportunity to meet and hear about the MoU – what is it, where we’re at and the significant to the industry, and what we can do as physicians in the industry to work with Medicines Australia more closer and effectively.
In January 2010 Dr Brendan Shaw was appointed Chief Executive of Medicines Australia. Brendan has been instrumental in guiding the pharmaceutical industry through reforms to the Pharmaceutical Benefits Scheme, the Pharmaceutical Benefits Advisory Committee processes and the Therapeutic Goods Administration. He has driven Medicines Australia’s research program, developed Joint Medicines Policy Conferences with the Australian Government, and Medicines Australia’s contribution to the international debate on health technology assessment.
For the last six years Dr Shaw led the Health Policy and Research function at Medicines Australia, representing the industry on the Pharmaceutical Benefits Pricing Authority, the Access to Medicines Working Group, and for two years was the industry member of the Economic Sub-Committee of the Pharmaceutical Benefits Advisory Committee.
Prior to taking up his appointment with Medicines Australia in January 2004, Dr Shaw was adviser to the then Shadow Minister for Innovation, Industry and Trade, Dr Craig Emerson MP. Dr Shaw has previously worked in academia, consulting and the Australian Government in the areas of economic development, innovation, industry analysis and public policy.
Please also take the opportunity to share drinks and canapés with us at the conclusion of the meeting.
Event RSVP
